{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:15:54Z","timestamp":1793103354692,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejim.2023.10.019","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T15:29:50Z","timestamp":1697902190000},"page":"99-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Crohn\u00b4s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0857-8117","authenticated-orcid":false,"given":"Samuel J.","family":"Mart\u00ednez-Dom\u00ednguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2670-3922","authenticated-orcid":false,"given":"Sandra","family":"Garc\u00eda-Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla J.","family":"Gargallo-Puyuelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Gallego Llera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engy","family":"Refaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Callau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Mendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro M.","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Hern\u00e1ndez Ainsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Arroyo-Villarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"L\u00f3pez de la Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2289-1719","authenticated-orcid":false,"given":"Javier","family":"Mart\u00ednez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Alfambra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Sim\u00f3n Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Ampuero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gomoll\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejim.2023.10.019_bib0001","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"13","key":"10.1016\/j.ejim.2023.10.019_bib0002","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.3390\/jcm10132885","article-title":"Incidence, clinical characteristics and management of inflammatory bowel disease in spain: large-scale epidemiological study","volume":"10","author":"Chaparro","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.ejim.2023.10.019_bib0003","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/nu14040751","article-title":"Nutrition in patients with inflammatory bowel diseases: a narrative review","volume":"14","author":"Roncoroni","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ejim.2023.10.019_bib0004","article-title":"ESPEN guideline: clinical nutrition in inflammatory bowel disease","author":"Bischoff","year":"2022","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.ejim.2023.10.019_bib0005","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella","year":"2023","journal-title":"Hepatol Baltim Md"},{"issue":"10319","key":"10.1016\/j.ejim.2023.10.019_bib0006","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL\u2013Lancet liver commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ejim.2023.10.019_bib0007","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41575-020-0316-6","article-title":"From NAFLD to MAFLD: when pathophysiology succeeds","volume":"17","author":"Tilg","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.ejim.2023.10.019_bib0008","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.3390\/nu13082772","article-title":"The other side of malnutrition in inflammatory bowel disease (IBD): non-alcoholic fatty liver disease","volume":"13","author":"Gibiino","year":"2021","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.ejim.2023.10.019_bib0009","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ejim.2023.10.019_bib0010","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.ejim.2023.10.019_bib0011","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/j.crohns.2012.10.015","article-title":"Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease","volume":"7","author":"Sourianarayanane","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.ejim.2023.10.019_bib0012","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00384-016-2706-3","article-title":"Liver test abnormalities predict complicated disease behaviour in patients with newly diagnosed Crohn's disease","volume":"32","author":"Barendregt","year":"2017","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ejim.2023.10.019_bib0013","article-title":"High prevalence of non-alcoholic fatty liver disease in patients with inflammatory bowel disease receiving anti-tumor necrosis factor therapy","author":"Likhitsup","year":"2019","journal-title":"Ann Gastroenterol"},{"issue":"2","key":"10.1016\/j.ejim.2023.10.019_bib0014","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ejim.2023.10.019_bib0015","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","year":"2021","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.ejim.2023.10.019_bib0016","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2021.12.031","article-title":"Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events","volume":"76","author":"Boursier","year":"2022","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.ejim.2023.10.019_bib0017","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders","volume":"11","author":"Magro","year":"2017","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10.1016\/j.ejim.2023.10.019_bib0018","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016. Part 1: diagnosis and medical management","volume":"11","author":"Gomoll\u00f3n","year":"2017","journal-title":"J Crohns Colitis"},{"issue":"40","key":"10.1016\/j.ejim.2023.10.019_bib0019","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","article-title":"Ultrasound-based techniques for the diagnosis of liver steatosis","volume":"25","author":"Ferraioli","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.ejim.2023.10.019_bib0020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.gastrohep.2017.12.003","article-title":"Documento de consenso. Manejo de la enfermedad hep\u00e1tica grasa no alcoh\u00f3lica (EHGNA). Gu\u00eda de pr\u00e1ctica cl\u00ednica","volume":"41","author":"Aller","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2023.10.019_bib0021","series-title":"Enfermedad de h\u00edgado graso no alcoh\u00f3lico: un estudio integral","first-page":"200","year":"2021"},{"issue":"6","key":"10.1016\/j.ejim.2023.10.019_bib0022","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2023.10.019_bib0023","first-page":"1","article-title":"Frequency of hepatobiliary manifestations and concomitant liver disease in inflammatory bowel disease patients","volume":"2019","author":"Silva","year":"2019","journal-title":"BioMed Res Int"},{"issue":"46","key":"10.1016\/j.ejim.2023.10.019_bib0024","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.3748\/wjg.v26.i46.7367","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: a cross-sectional and longitudinal analysis","volume":"26","author":"Hoffmann","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ejim.2023.10.019_bib0025","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.cgh.2022.01.039","article-title":"Increased risk of MAFLD and liver fibrosis in inflammatory bowel disease independent of classic metabolic risk factors","volume":"21","author":"Rodriguez-Duque","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.ejim.2023.10.019_bib0026","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"10290","key":"10.1016\/j.ejim.2023.10.019_bib0027","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejim.2023.10.019_bib0028","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00384-021-04065-8","article-title":"Disease activity in inflammatory bowel disease patients is associated with increased liver fat content and liver fibrosis during follow-up","volume":"37","author":"van Lingen","year":"2022","journal-title":"Int J Colorectal Dis"},{"issue":"13","key":"10.1016\/j.ejim.2023.10.019_bib0029","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.cgh.2019.02.045","article-title":"Crohn's disease is associated with an increased prevalence of nonalcoholic fatty liver disease: a cross-sectional study using magnetic resonance proton density fat fraction mapping","volume":"17","author":"McHenry","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.ejim.2023.10.019_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252286","article-title":"Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: a Taiwanese retrospective cohort study","volume":"16","author":"Yen","year":"2021","journal-title":"PLOS One"},{"issue":"2","key":"10.1016\/j.ejim.2023.10.019_bib0031","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41419-017-0124-2","article-title":"Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease","volume":"9","author":"Sartini","year":"2018","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.ejim.2023.10.019_bib0032","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/MIB.0000000000001085","article-title":"Epidemiology and risk factors of nonalcoholic fatty liver disease among patients with inflammatory bowel disease","volume":"23","author":"Glassner","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.ejim.2023.10.019_bib0033","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/hepr.12828","article-title":"Significance of non-alcoholic fatty liver disease in Crohn's disease: a retrospective cohort study: NAFLD significance in Crohn's disease","volume":"47","author":"Sagami","year":"2017","journal-title":"Hepatol Res"},{"issue":"8","key":"10.1016\/j.ejim.2023.10.019_bib0034","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/MIB.0000000000000832","article-title":"Incidence and predictors of nonalcoholic fatty liver disease by serum biomarkers in patients with inflammatory bowel disease","volume":"22","author":"Bessissow","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"37","key":"10.1016\/j.ejim.2023.10.019_bib0035","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.3748\/wjg.v25.i37.5676","article-title":"Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: beyond the natural history","volume":"25","author":"Magr\u00ec","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.ejim.2023.10.019_bib0036","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/ibd\/izy051","article-title":"Nonalcoholic fatty liver disease in inflammatory bowel disease: prevalence and risk factors","volume":"24","author":"Principi","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.ejim.2023.10.019_bib0037","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/ibd\/izy200","article-title":"Screening for nonalcoholic fatty liver disease in inflammatory bowel diseases: a cohort study using transient elastography","volume":"25","author":"Saroli Palumbo","year":"2019","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.ejim.2023.10.019_bib0038","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s10620-017-4495-0","article-title":"Intestinal inflammation does not predict nonalcoholic fatty liver disease severity in inflammatory bowel disease patients","volume":"62","author":"Carr","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1016\/j.ejim.2023.10.019_bib0039","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3109\/00365521.2015.1064995","article-title":"Prevalence and prognostic value of hepatic histological alterations in patients with Crohn's disease","volume":"50","author":"Ribaldone","year":"2015","journal-title":"Scand J Gastroenterol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523003746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523003746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T18:39:00Z","timestamp":1715884740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620523003746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":39,"alternative-id":["S0953620523003746"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2023.10.019","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crohn\u00b4s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2023.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}